262 related articles for article (PubMed ID: 8628165)
1. Managing HIV. Part 4: Primary therapy. 4.1 Antiretroviral therapies for HIV.
Crowe S; Cooper DA; Chambers DE
Med J Aust; 1996 Mar; 164(5):290-5. PubMed ID: 8628165
[TBL] [Abstract][Full Text] [Related]
2. Studies of zidovudine in combination with didanosine and zalcitabine.
Jablonowski H
J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S52-6. PubMed ID: 8595509
[TBL] [Abstract][Full Text] [Related]
3. Combined drugs may be better than zidovudine alone for immunocompromised adults infected with HIV-1.
Commun Dis Rep CDR Wkly; 1995 Oct; 5(42):209. PubMed ID: 7496435
[No Abstract] [Full Text] [Related]
4. Antiretroviral drugs: new agents, new combinations line up against HIV.
Phillips L
Hosp Technol Ser; 1996 Jan; 15(1):1-3. PubMed ID: 10161344
[No Abstract] [Full Text] [Related]
5. [Antiretroviral therapy. Current status and perspectives].
Lüthy R
Internist (Berl); 1994 Oct; 35(10):896-900. PubMed ID: 8002223
[No Abstract] [Full Text] [Related]
6. Anti-HIV therapy lowers risk of AIDS, death in patients with intermediate-stage HIV disease.
AIDS Patient Care; 1995 Dec; 9(6):303. PubMed ID: 11361440
[No Abstract] [Full Text] [Related]
7. Combination therapy increases survival.
Treat Rev; 1995 Nov; (no 20):2-3. PubMed ID: 11363019
[TBL] [Abstract][Full Text] [Related]
8. What we know about anti-HIV drugs.
Treat Rev; 1995 May; (no 18):3-4. PubMed ID: 11362592
[TBL] [Abstract][Full Text] [Related]
9. [Treatment by antiviral drugs of HIV-infected patients].
Mayaud C
Rev Pneumol Clin; 1993; 49(2):71-4. PubMed ID: 8272744
[No Abstract] [Full Text] [Related]
10. 3TC/AZT: just another combination.
GMHC Treat Issues; 1995 Dec; 9(12):2. PubMed ID: 11362997
[TBL] [Abstract][Full Text] [Related]
11. Study results at a glance.
AIDS Alert; 1995 Nov; 10(11):134. PubMed ID: 11362922
[TBL] [Abstract][Full Text] [Related]
12. 3TC: combination trial stopped early as clinical benefit shown.
James JS
AIDS Treat News; 1996 Aug; (no 252):5. PubMed ID: 11363752
[TBL] [Abstract][Full Text] [Related]
13. Antiretroviral drug resistance.
Japour AJ
AIDS Clin Care; 1995 Aug; 7(8):63-5, 67. PubMed ID: 11362787
[TBL] [Abstract][Full Text] [Related]
14. New developments in antiretroviral drug therapy for HIV infection.
Johnson VA
AIDS Clin Rev; 1992; ():69-104. PubMed ID: 1318738
[No Abstract] [Full Text] [Related]
15. AZT studies reinforce benefits of combination.
AIDS Alert; 1995 Jan; 10(1):11-2. PubMed ID: 11362167
[TBL] [Abstract][Full Text] [Related]
16. [Results of two studies: Delta I/II and ACTG 175].
Biehler GV
Sidahora; 1996 Dec-1997 Jan; ():37-40. PubMed ID: 11363441
[TBL] [Abstract][Full Text] [Related]
17. [Antiretroviral treatment against HIV].
González-Lahoz J; Soriano V
Med Clin (Barc); 1995 Sep; 105(10):377-8. PubMed ID: 7475441
[No Abstract] [Full Text] [Related]
18. Closing the circle on HIV--or not.
Mascolini M
J Int Assoc Physicians AIDS Care; 1995 Oct; 1(9):10-4, 17-29 contd. PubMed ID: 11362964
[TBL] [Abstract][Full Text] [Related]
19. AZT combination trial shows positive results.
Nature; 1995 Sep; 377(6547):277. PubMed ID: 7566074
[No Abstract] [Full Text] [Related]
20. Therapy for human immunodeficiency virus infection -- what have we learned?
Corey L; Holmes KK
N Engl J Med; 1996 Oct; 335(15):1142-4. PubMed ID: 8813046
[No Abstract] [Full Text] [Related]
[Next] [New Search]
